Telematics company Trakm8 (LON: TRAK) is being acquired by Canadian software company Constellation Software Inc. The recommended bid is 9.5p/share in cash and the share price recovered 254% to 8.85p. Weak demand from the vehicle insurance sector and delays to an expected optimisation contract hit trading at Trakm8 and it has been cutting costs. Constellation Software is attracted to Trakm8’s strong market position in the UK and it will provide greater financial backing. Fellow AIM telematics company Microlise (LON: SAAS) has a 20% stake in Trakm8 as well as a convertible loan. Microlise shares rose 9.6% to 108.5p.
Versarien (LON: VRS) says that a court hearing for the case brought by former chief executive Neill Ricketts has been scheduled for between 23 February and 6 March 2026. The share price increased 61.5% to 0.042p.
Lung cancer diagnostics developer LungLife AI Inc (LON: LLAI) set the date of a special meeting to gain approval for the licence and distribution deal with Circulogene Theranostics and the departure from AIM. It will be held on 20 May. The share price rebounded 55.6% to 3.5p.
Richard Deacon has built up a 7.3% shareholding in United Oil & Gas (LON: UOG). The share price improved 52.4% to 0.16p.
Data and analytics information provider GlobalData (LON: DATA), which is in the process of moving to the Main Market, has received bid approaches from two private equity investors. This led to the suspension of a £50m share buyback. The share price rose 40.8% to 195p.
FALLERS
In content advertising company Mirriad Advertising (LON: MIRI) says first quarter revenues were just over £80,000, although this is a seasonally weak period there were lower than expected activity levels. Cash has fallen to £2.7m at the end of March 2025 with monthly cash burn of up to £750,000. There were talks about a possible offer for the company, but they have ended. Mirriad Advertising needs to raise more cash, and management is considering placing the company in administration. M&G has sold its 11.6% shareholding. The share price slumped 92.1% to 0.03p.
Enteq Technologies (LON: NTQ) appointed administrators on 30 April after it failed to secure the additional funding to continue to meet its liabilities. The share price dipped 68.5% to 0.4875p prior to the suspension of trading.
Healthcare services provider Totally (LON: TLY) has launched a strategic review following a downgrading of expectations for the year to March 2025. This reflects a delay in the start of a contract and the discontinuing of higher margin NHS111 work. EBITDA expectations have been downgraded from £3.5m to between nil and £2m. Exceptional costs are higher than anticipated at £3.8m. The finance director has left. There is a tight cash position and that has sparked the review to decide how to strengthen the balance sheet. David and Sharon Hudaly revealed a 3.43% stake after the trading announcement. The share price slid 63.6% to 1.5p.
GENinCode (LON: GENI) says there are outstanding elements in the De Novo submission to the Food and Drug Administration for CARDIO inCode-Score. These relate to clinical validation, which will be addressed. A supervisory review has begun, and the company is in discussions with the FDA. This will extend the time to generating revenues in the US. The share price declined 37.8% to 1.525p.